Exhaled and nasal nitric oxide as a marker of pneumonia in ventilated patients.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 11316650)

Published in Am J Respir Crit Care Med on April 01, 2001

Authors

C Adrie1, M Monchi, A T Dinh-Xuan, J Dall'Ava-Santucci, J F Dhainaut, M R Pinsky

Author Affiliations

1: Medical Intensive Care Unit, and Respiratory Physiology Department, Cochin Port-Royal Hospital, University of Paris V, Paris, France. christophe.adrie@wanadoo.fr

Articles by these authors

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58

Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med (2001) 27.70

Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med (2000) 5.53

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA (1994) 5.24

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86

Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med (2001) 3.98

Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med (1997) 3.53

Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA (1999) 3.51

Long-term outcome of critically ill elderly patients requiring intensive care. JAMA (1993) 3.27

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med (1993) 2.84

Iatrogenic complications in adult intensive care units: a prospective two-center study. Crit Care Med (1993) 2.84

French intensivists do not apply American recommendations regarding decisions to forgo life-sustaining therapy. Crit Care Med (2001) 2.39

Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet (1991) 2.30

Clinical use of respiratory changes in arterial pulse pressure to monitor the hemodynamic effects of PEEP. Am J Respir Crit Care Med (1999) 2.28

Is the pulmonary artery catheter misused? A European view. Crit Care Med (1998) 2.23

Quality-adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Med (2001) 2.18

Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med (1998) 2.14

Strong ion gap: a methodology for exploring unexplained anions. J Crit Care (1995) 2.09

Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med (1998) 2.05

Effect of intrathoracic pressure on left ventricular performance. N Engl J Med (1979) 2.01

Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest (1998) 1.92

European union standards for tuberculosis care. Eur Respir J (2012) 1.73

The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med (1998) 1.71

Hemodynamic profile in severe ARDS: results of the European Collaborative ARDS Study. Intensive Care Med (1998) 1.71

Release of lactate by the lung in acute lung injury. Chest (1997) 1.66

Quantifying learning in medical students during a critical care medicine elective: a comparison of three evaluation instruments. Crit Care Med (2001) 1.65

Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis. Eur Respir J (2011) 1.63

Estimating cardiac filling pressure in mechanically ventilated patients with hyperinflation. Crit Care Med (2000) 1.57

Noninvasive cardiac output monitoring by aortic blood flow determination: evaluation of the Sometec Dynemo-3000 system. Crit Care Med (1998) 1.56

Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop. Am J Respir Crit Care Med (1999) 1.53

Meeting the needs of intensive care unit patient families: a multicenter study. Am J Respir Crit Care Med (2001) 1.52

Pre-hospital transcranial Doppler in severe traumatic brain injury: a pilot study. Acta Anaesthesiol Scand (2011) 1.51

The hepatopulmonary syndrome: NO way out? Eur Respir J (2004) 1.49

Increased nitric oxide in exhaled air in patients with systemic sclerosis. Clin Exp Rheumatol (1998) 1.48

Assessment of left ventricular contractile state by preload-adjusted maximal power using echocardiographic automated border detection. J Am Coll Cardiol (1998) 1.45

Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation (1987) 1.44

Defining the hypoxic threshold. Crit Care Med (1991) 1.44

Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients. Thorax (2004) 1.43

Quantitative assessment of alterations in regional left ventricular contractility with color-coded tissue Doppler echocardiography. Comparison with sonomicrometry and pressure-volume relations. Circulation (1997) 1.43

Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation. J Thorac Cardiovasc Surg (1992) 1.42

Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci (1999) 1.41

Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med (2001) 1.41

NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med (2000) 1.41

Is tracheal gas insufflation an alternative to extrapulmonary gas exchangers in severe ARDS? Chest (1995) 1.40

Refractory cardiac arrest in a rural area: mechanical chest compression during helicopter transport. Acta Anaesthesiol Scand (2012) 1.39

Respiratory sinus arrhythmia in the denervated human heart. J Appl Physiol (1985) (1989) 1.39

Lack of efficacy of inhaled nitric oxide in ARDS. Intensive Care Med (1994) 1.38

The effect of managed care on ICU length of stay: implications for medicare. JAMA (1996) 1.35

LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. Am J Respir Crit Care Med (1999) 1.35

The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling. Intensive Care Med (1998) 1.32

Reproducibility of thermodilution cardiac output determination in critically ill patients: comparison between bolus and continuous method. J Clin Monit (1996) 1.28

Compliance with triage to intensive care recommendations. Crit Care Med (2001) 1.28

Etiology of metabolic acidosis during saline resuscitation in endotoxemia. Shock (1998) 1.25

Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med (2001) 1.23

The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med (2000) 1.22

Determinants of pulmonary arterial flow variation during respiration. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.20

Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. Br Heart J (1993) 1.17

Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc (1987) 1.17

Protective effects of hsp70 in inflammation. Experientia (1994) 1.16

Blood gas measurement during exercise: a comparative study between arterialized earlobe sampling and direct arterial puncture in adults. Eur Respir J (1998) 1.15

Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care (1993) 1.15

Instantaneous venous return curves in an intact canine preparation. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.15

Short-term and long-term outcome prediction with the Acute Physiology and Chronic Health Evaluation II system after orthotopic liver transplantation. Crit Care Med (2000) 1.14

Combined chemotherapy including rifabutin for rifampicin and isoniazid resistant pulmonary tuberculosis. G.E.T.I.M. (Group for the Study and Treatment of Resistant Mycobacterial Infection). Eur Respir J (1992) 1.13

Current understanding of sepsis. Clin Infect Dis (1996) 1.10

L-Carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues. AIDS (2000) 1.10

Medical students can learn the basic application, analytic, evaluative, and psychomotor skills of critical care medicine. Crit Care Med (2000) 1.09

The inflammatory balance in human sepsis. Intensive Care Med (2000) 1.08

Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension. Circulation (1996) 1.07

Study of prone positioning to reduce ventilator-associated pneumonia in hypoxaemic patients. Eur Respir J (2009) 1.07

Technology comparison studies require precise reference controls to be valid. Br J Anaesth (2013) 1.07

Bedside evaluation of right ventricular performance using a rapid computerized thermodilution method. Crit Care Med (1987) 1.06

Combination therapy for pulmonary arterial hypertension: still more questions than answers. Eur Respir J (2004) 1.06

Hepatic anion flux during acute endotoxemia. J Appl Physiol (1985) (1995) 1.05

Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock. Intensive Care Med (1996) 1.04

Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med (1999) 1.03

Implications of arterial pressure variation in patients in the intensive care unit. Curr Opin Crit Care (2001) 1.03

Measurements of right ventricular volumes during fluid challenge. Chest (1990) 1.02

Right ventricular function in human sepsis: a thermodilution study. Chest (1997) 1.02

Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension. Am J Respir Crit Care Med (1998) 1.01

Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography. J Am Coll Cardiol (2001) 1.00

Beyond global oxygen supply-demand relations: in search of measures of dysoxia. Intensive Care Med (1994) 0.99

Is intensive care justified for patients with haematological malignancies? Intensive Care Med (1990) 0.99

Augmentation of cardiac function by elevation of intrathoracic pressure. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.99

Vitamin A decreases the incidence and severity of nitrofen-induced congenital diaphragmatic hernia in rats. Am J Physiol (1999) 0.98

A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome. Intensive Care Med (2001) 0.98

Decreased pulmonary and tracheal smooth muscle expression and activity of type 1 nitric oxide synthase (nNOS) after ovalbumin immunization and multiple aerosol challenge in guinea pigs. Am J Respir Crit Care Med (2001) 0.98

Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction. JAMA (1995) 0.98

Treatment with 815-nm diode laser induces long-lasting expression of 72-kDa heat shock protein in normal rat skin. Br J Dermatol (2001) 0.97